位置:首页 > 蛋白库 > PQSC_PSEAE
PQSC_PSEAE
ID   PQSC_PSEAE              Reviewed;         348 AA.
AC   Q9I4X1;
DT   25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 119.
DE   RecName: Full=2-heptyl-4(1H)-quinolone synthase subunit PqsC {ECO:0000305};
DE            EC=2.3.1.230 {ECO:0000269|PubMed:24239007, ECO:0000269|PubMed:26811339};
GN   Name=pqsC {ECO:0000303|PubMed:24239007};
GN   OrderedLocusNames=PA0998 {ECO:0000312|EMBL:AAG04387.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, SUBUNIT, SUBCELLULAR
RP   LOCATION, ACTIVE SITE, MUTAGENESIS OF CYS-129, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=PA14;
RX   PubMed=24239007; DOI=10.1016/j.chembiol.2013.09.021;
RA   Dulcey C.E., Dekimpe V., Fauvelle D.A., Milot S., Groleau M.C., Doucet N.,
RA   Rahme L.G., Lepine F., Deziel E.;
RT   "The end of an old hypothesis: the Pseudomonas signaling molecules 4-
RT   hydroxy-2-alkylquinolines derive from fatty acids, not 3-ketofatty acids.";
RL   Chem. Biol. 20:1481-1491(2013).
RN   [3] {ECO:0007744|PDB:5DWZ}
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) OF 2-348 IN COMPLEX WITH PQSB,
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, ACTIVE SITE, AND MUTAGENESIS OF HIS-269 AND VAL-299.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=26811339; DOI=10.1074/jbc.m115.708453;
RA   Drees S.L., Li C., Prasetya F., Saleem M., Dreveny I., Williams P.,
RA   Hennecke U., Emsley J., Fetzner S.;
RT   "PqsBC, a condensing enzyme in the biosynthesis of the Pseudomonas
RT   aeruginosa quinolone signal: crystal structure, inhibition, and reaction
RT   mechanism.";
RL   J. Biol. Chem. 291:6610-6624(2016).
CC   -!- FUNCTION: Required for the biosynthesis of the quorum-sensing signaling
CC       molecules 2-heptyl-4(1H)-quinolone (HHQ) and 2-heptyl-3-hydroxy-4(1H)-
CC       quinolone (Pseudomonas quinolone signal or PQS), which are important
CC       for biofilm formation and virulence. The PqsC/PqsB complex catalyzes
CC       the condensation of 2-aminobenzoylacetate (2-ABA) and octanoyl-CoA to
CC       form HHQ. First, PqsC acquires an octanoyl group from octanoyl-CoA and
CC       forms an octanoyl-PqsC intermediate. Then, together with PqsB, it
CC       catalyzes the coupling of 2-ABA with the octanoate group, leading to
CC       decarboxylation and dehydration, and resulting in closure of the
CC       quinoline ring. {ECO:0000269|PubMed:24239007,
CC       ECO:0000269|PubMed:26811339}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2-aminobenzoyl)acetate + H(+) + octanoyl-CoA = 2-heptyl-
CC         4(1H)-quinolone + CO2 + CoA + H2O; Xref=Rhea:RHEA:50396,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57386, ChEBI:CHEBI:62219,
CC         ChEBI:CHEBI:131446; EC=2.3.1.230;
CC         Evidence={ECO:0000269|PubMed:24239007, ECO:0000269|PubMed:26811339};
CC   -!- ACTIVITY REGULATION: Folding of PqsC and binding of octanoate are
CC       promoted by PqsB (PubMed:24239007). Binding of the octanoyl group
CC       probably increases the binding affinity of the complex for 2-ABA
CC       (PubMed:26811339). Activity of the complex is inhibited by 2-
CC       aminoacetophenone (2-AA) (PubMed:26811339).
CC       {ECO:0000269|PubMed:24239007, ECO:0000269|PubMed:26811339}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6.0 uM for octanoyl-CoA (in the presence of PqsB)
CC         {ECO:0000269|PubMed:26811339};
CC         KM=105 uM for 2-ABA (in the presence of PqsB)
CC         {ECO:0000269|PubMed:26811339};
CC         Note=kcat is 6.8 sec(-1). {ECO:0000269|PubMed:26811339};
CC   -!- SUBUNIT: Forms a tight complex with PqsB. {ECO:0000269|PubMed:24239007,
CC       ECO:0000269|PubMed:26811339}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24239007}.
CC   -!- SIMILARITY: Belongs to the thiolase-like superfamily. FabH family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG04387.1; -; Genomic_DNA.
DR   PIR; A83522; A83522.
DR   RefSeq; NP_249689.1; NC_002516.2.
DR   RefSeq; WP_003108612.1; NZ_QZGE01000006.1.
DR   PDB; 5DWZ; X-ray; 2.04 A; C/D/F/H=2-348.
DR   PDB; 6ESZ; X-ray; 1.84 A; A/C=1-348.
DR   PDB; 6ET0; X-ray; 1.53 A; A/C=1-348.
DR   PDB; 6ET1; X-ray; 2.65 A; A/C/E/G=1-348.
DR   PDB; 6ET2; X-ray; 2.60 A; A/C/E/G/I/K/M/O=1-348.
DR   PDB; 6ET3; X-ray; 2.25 A; A/C=1-348.
DR   PDBsum; 5DWZ; -.
DR   PDBsum; 6ESZ; -.
DR   PDBsum; 6ET0; -.
DR   PDBsum; 6ET1; -.
DR   PDBsum; 6ET2; -.
DR   PDBsum; 6ET3; -.
DR   AlphaFoldDB; Q9I4X1; -.
DR   SMR; Q9I4X1; -.
DR   STRING; 287.DR97_949; -.
DR   PaxDb; Q9I4X1; -.
DR   PRIDE; Q9I4X1; -.
DR   DNASU; 880660; -.
DR   EnsemblBacteria; AAG04387; AAG04387; PA0998.
DR   GeneID; 880660; -.
DR   KEGG; pae:PA0998; -.
DR   PATRIC; fig|208964.12.peg.1030; -.
DR   PseudoCAP; PA0998; -.
DR   HOGENOM; CLU_039592_1_0_6; -.
DR   InParanoid; Q9I4X1; -.
DR   OMA; MDSNANC; -.
DR   PhylomeDB; Q9I4X1; -.
DR   BioCyc; MetaCyc:MON-19873; -.
DR   BioCyc; PAER208964:G1FZ6-1017-MON; -.
DR   BRENDA; 2.3.1.230; 5087.
DR   BRENDA; 2.3.1.B38; 5087.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IMP:PseudoCAP.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR013751; ACP_syn_III.
DR   InterPro; IPR013747; ACP_syn_III_C.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF08545; ACP_syn_III; 1.
DR   Pfam; PF08541; ACP_syn_III_C; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Cytoplasm; Reference proteome; Transferase.
FT   CHAIN           1..348
FT                   /note="2-heptyl-4(1H)-quinolone synthase subunit PqsC"
FT                   /id="PRO_0000441875"
FT   ACT_SITE        129
FT                   /note="Acyl-thioester intermediate"
FT                   /evidence="ECO:0000305|PubMed:24239007,
FT                   ECO:0000305|PubMed:26811339"
FT   ACT_SITE        269
FT                   /evidence="ECO:0000305|PubMed:26811339"
FT   MUTAGEN         129
FT                   /note="C->A,S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:24239007"
FT   MUTAGEN         269
FT                   /note="H->A: Alters binding properties for both 2-ABA and
FT                   2-AA. Almost loss of activity."
FT                   /evidence="ECO:0000269|PubMed:26811339"
FT   MUTAGEN         299
FT                   /note="V->N: Has significant activity toward the desamino
FT                   substrate analog benzoylacetate."
FT                   /evidence="ECO:0000269|PubMed:26811339"
FT   STRAND          4..12
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          17..19
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           23..25
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           33..39
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           49..51
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           57..69
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           74..76
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   TURN            93..95
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           108..115
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          121..124
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           128..130
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           131..144
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          149..157
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           159..162
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          176..184
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          186..199
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          207..212
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:6ET3"
FT   STRAND          224..229
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           233..237
FT                   /evidence="ECO:0007829|PDB:6ET3"
FT   HELIX           240..256
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           260..262
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          264..268
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           273..283
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           287..289
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           294..297
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   HELIX           304..314
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          323..330
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   TURN            331..333
FT                   /evidence="ECO:0007829|PDB:6ET0"
FT   STRAND          334..341
FT                   /evidence="ECO:0007829|PDB:6ET0"
SQ   SEQUENCE   348 AA;  38239 MW;  DBBBDA8DE2B4A559 CRC64;
     MHKVKLAAIT CELPARSYEN DDPVFAAVPD LSESWWQFWG VNRRGYFDPR NGENEFSLVV
     RAAERLLRSS DTAPDSVDML ICSASSPIMT DAGDVLPDLR GRLYPRMANV LSKQLGLSRA
     LPLDSQMECA SFLLNLRLAA SMIRQGKAEK VLVVCSEYIS NLLDFTSRTS TLFADGCAVA
     LLTRGDDDSC DLLASAEHSD ATFYEVATGR WRLPENPTGE AKPRLYFSLF SDGQNKMASF
     VPTNVPIAMR RALEKAGLGS DDIDYFVFHQ PAPFLVKAWA EGIGARPEQY QLTMGDTGVM
     ISVSIPYTLM TGLREGKIRP GDRIVMAGAA TGWGFAAQVW QLGEVLVC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024